Stockscreener 앱 받기
4.9001
4.26%
0.2001
전일 마감가:
$4.70
열려 있는:
$4.92
하루 거래량:
11,490
Relative Volume:
0.04
시가총액:
$33.00M
수익:
-
순이익/손실:
$-72.26M
주가수익비율:
-2.3787
EPS:
-2.06
순현금흐름:
$-68.44M
1주 성능:
-16.09%
1개월 성능:
+304.97%
6개월 성능:
+304.97%
1년 성능:
+308.34%
1일 변동 폭
$4.81
$4.95
1주일 범위
$4.39
$5.44
52주 변동 폭
$1.20
$10.84
레인 테라퓨틱스 Stock (RAIN) Company Profile
RAIN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RAIN
Rain Enhancement Technologies Holdco Inc
|
4.81 | 33.00M | 0 | -72.26M | -68.44M | -2.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
410.20 | 106.10B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
703.39 | 77.86B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
661.49 | 39.50B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.14 | 30.44B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
121.68 | 29.15B | 3.30B | -501.07M | 1.03B | -2.1146 |
레인 테라퓨틱스 Stock (RAIN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-03-21 | 개시 | SVB Securities | Outperform |
| 2023-01-31 | 재개 | ROTH Capital | Buy |
| 2023-01-23 | 개시 | Mizuho | Buy |
| 2022-09-12 | 개시 | H.C. Wainwright | Buy |
| 2022-04-01 | 개시 | Oppenheimer | Outperform |
| 2021-09-14 | 재개 | Goldman | Neutral |
| 2021-07-20 | 개시 | Piper Sandler | Overweight |
| 2021-05-18 | 개시 | Citigroup | Buy |
| 2021-05-18 | 개시 | Goldman | Buy |
| 2021-05-18 | 개시 | Guggenheim | Buy |
| 2021-05-18 | 개시 | Piper Sandler | Overweight |
모두보기
레인 테라퓨틱스 주식(RAIN)의 최신 뉴스
Dell Technologies Leads AI PC Movement with New, Redesigned PC Portfolio - Quantisnow
Stock market today: NextNav -22.28%, Intrusion -19.76% among biggest losers in early trading - Business Upturn
Stock market today: AEON Biopharma saw gain of 255.62% while SciSparc increased by 89.77% in early trading - Business Upturn
Bad weather alert for Sabah, Sarawak and Labuan - The Malaysian Reserve
Stock market news: Dogness (International) -25.96%, Heartcore Enterprises -21.48% among biggest losers during mid day trading - Business Upturn
FTSE 100 Holds Steady as Energy Shares Offset Sectoral Declines – Market - HPBL
FTSE 100 Pauses After Weekly Surge Amid Energy Gains and Retail Challenges – Market - HPBL
FTSE 100 Rallies While NASDAQ 100 Wavers: A Tale of Two Indices – Market - HPBL
DAX Begins 2025 Strong: Can It Break the 20,523 Record High? – Market - HPBL
Latham, Paul Weiss, Debevoise Land on Year-End Big Deals. But Geopolitical Uncertainty Could Slow M&A Growth in 2025 - Law.com International
Deal Watch: Latham, Paul Weiss, Debevoise Land on Year-End Big Deals. Plus, Mixed Messages for 2025 M&A - Law.com
Stock market news: Rain Oncology +371.17%, SuperCom +75.93% among top gainers during mid day trading - Business Upturn
Stock market news: Neumora Therapeutics down by 80.75% while N2OFF surged by 333.47% during mid day trading - Business Upturn
Spain IBEX 35 Rises on Energy and Consumer Goods Gains, Gold and Oil Prices Surge – Market - HPBL
Fidelity MSCI Financials Index ETF (FNCL): A Cost-Effective Gateway to the Financial Sector – Market - HPBL
Fidelity Boosts Valuation of Elon Musk X by 32%, Signaling Renewed Optimism – Market - HPBL
JPMorgan Global Growth & Income Plc Issues 200,000 Shares, Raising Capital for Future Strategy - HPBL
Neumora Therapeutics and Other Stocks Suffer Major Losses as Market Faces Declines - HPBL
Rain Oncology, Alset Inc., and Other Stocks Surge as Investors Eye Market Opportunities - HPBL
Neumora Therapeutics, Rain Oncology, and Carmell Corporation: Stock Volatility Highlights Major Market Moves - HPBL
Tech Stocks Display Mixed Performance in Early Market Trading: Tesla Drops While MicroStrategy Soars - HPBL
Trump Media & Technology Group (DJT) Sees Modest Stock Rise Amid Volatility – Market - HPBL
3 Vanguard ETF to Buy in 2025 for Higher Yields and Lower P/E Ratios Amid Market Volatility - HPBL
Stock market today: Neumora Therapeutics down by 81.14% while Rain Oncology surged by 676.86% in early trading - Business Upturn
Stock market today: Rain Oncology +603.31%, Alset +103.93% among top gainers in early trading - Business Upturn
Rain Enhancement Technologies Completes Business Combination with Coliseum Acquisition - Defense World
Tuesday’s Insider Activity: Top Buys and Sells in US Stocks Revealed - Investing.com Nigeria
Tuesday's Insider Activity: Top Buys and Sells in US Stocks Revealed - Investing.com Australia
Rain enhancement technologies investor Paul Dacier buys $100k in stock By Investing.com - Investing.com India
Rain Enhancement Technologies Goes Public on Nasdaq, Promising 16% More Rainfall with Breakthrough Tech - StockTitan
U.S. Stock Market Nears Historic Finish as S&P 500 Set for Strong Year-End Gains – Market - HPBL
CrowdStrike Holdings (CRWD): A Cybersecurity Leader Positioned for Strong Growth in 2025 - HPBL
Nasdaq 100, Dow Jones, and S&P 500 Technical Analysis: Market Trends Heading into 2025 - HPBL
Wall Street Holiday Schedule: US Stock Markets Close Early on December 31, 2024 for New Year Celebration - HPBL
Indian Stock Market to Stay Open on New Year Day 2025: Here What You Need to Know - HPBL
Wall Street Set for Modest Gains on Final Day of 2024 Amid Strong Year-End Performance – Market - HPBL
Ather Energy IPO: What You Need to Know About Its Market Debut and Future Plans – Market - HPBL
US Stocks Surge to Historic Heights in 2024: S&P 500’s Back-to-Back 20% Gains and What It Means for Investors - HPBL
Boeing Stock Drops After Jeju Air Boeing 737-800 Crash in South Korea, Killing 179 People – Market - HPBL
Spanish Stock Market Set to Close 2024 Strong Amid Global Uncertainty – Market - HPBL
Coliseum Acquisition Corp. Faces Nasdaq Trading Suspension - Defense World
Coliseum Acquisition Corp. faces Nasdaq delisting, extends merger deadline By Investing.com - Investing.com South Africa
Coliseum Acquisition Corp. faces Nasdaq delisting, extends merger deadline - Investing.com India
MITAU stock touches 52-week low at $9.67 amid market shifts - Investing.com
Coliseum Acquisition Corp. Announces Redemption Reversals and Potential Purchases of Public Shares - Defense World
Biliary Tract Cancer Market Expected to Experience Major Growth by 2034, According to DelveInsight - EIN News
Coliseum Acquisition Corp. allows redemption reversal ahead of meetings - Investing.com
Coliseum Acquisition Corp. enters definitive agreement ahead of merger By Investing.com - Investing.com South Africa
Germ Cell Tumors Market to Register Significant Growth at a CAGR of 5.5% by 2034 | DelveInsight - The Malaysian Reserve
MET Targeting Therapies Market Set for Significant Growth by 2034: Key Trends and Insights | DelveInsight - GlobeNewswire
Coliseum Acquisition Corp. Reminds Shareholders to Vote in Connection with Business Combination and Extension - Business Wire
레인 테라퓨틱스 (RAIN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.32%
0.45%
자본화:
|
볼륨(24시간):